Table 2.
BECN1 and BRCA1 expression association with clinical features (METABRIC cohort).
|
BECN1 expression |
BRCA1 expression |
|||||||
|---|---|---|---|---|---|---|---|---|
| mRNA expression |
Odds ratio (95% confidence interval) | P value | mRNA expression |
Odds ratio (95% confidence interval) | P value | |||
| High | Low | High | Low | |||||
| PAM50 subtypes | ||||||||
| Luminal A/B | 804 | 409 | Reference | 656 | 557 | Reference | ||
| HER2-enriched | 63 | 177 | 5.5 [4.0, 7.7] | 1.4E− 30 | 136 | 104 | 0.9 [0.7, 1.2] | 0.48 |
| Basal-like | 54 | 277 | 10.0 [7.3, 14.1] | 1.4E− 61 | 168 | 163 | 1.1 [0.9, 1.5] | 0.29 |
| TP53 mutation | ||||||||
| Wild type | 423 | 298 | Reference | 345 | 376 | Reference | 0.52 | |
| Mutant | 32 | 67 | 3.0 [1.9, 4.8] | 8.9E− 07 | 51 | 48 | 0.9 [0.6, 1.3] | |
| Tumor grade | ||||||||
| I | 111 | 59 | Reference | 53 | 117 | Reference | ||
| II | 462 | 313 | 1.3 [0.9, 1.8] | 0.194 | 371 | 404 | 0.5 [0.3, 0.7] | 8.3E− 05 |
| III | 379 | 578 | 2.9 [2.0, 4.1] | 5.8E− 10 | 526 | 431 | 0.4 [0.3, 0.5] | 1.1E− 08 |